MERTK and RAC1P29S Drive Melanoma Cannibalism of T cells
Abstract
Metastatic melanoma cells are cannibalistic, engulfing living and dead lymphocytes, but the molecular mechanisms that drive this behavior, including how they recognize their targets, are unknown. RAC is a Rho family GTPase that plays a key role in F-actin dynamics. RAC1P29S is a hyperactivating driver mutation that is common in melanoma where it promotes proliferation, motility, and therapy-resistance. Here we show that RAC1P29S melanoma cells engulf more Jurkat T cells than an isogenic RAC1WT revertant line. Live imaging captured lamellipodial dynamics and whole-cell engulfment in real time. An inhibitor screen across RAC1P29S and RAC1WT patient-derived lines showed that cannibalism requires the phosphatidylserine receptor MERTK. A RAC1P29S line lacking detectable MERTK was not cannibalistic, indicating that RAC1 hyperactivity amplifies a specific, receptor-mediated response. RAC1P29S lines are sensitive to RAC and Arp2/3 inhibition. We propose a "grip and gulp" model in which MERTK provides the grip and Arp2/3-driven branched actin the gulp.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Hyperactive Rac1 drives MAPK-independent proliferation in melanoma by assembly of a mechanosensitive dendritic actin network
Ashwathi S. Mohan, Kevin M. Dean, … Gaudenz Danuser·bioRxiv·May 22, 2018
- Targeting effector pathways in RAC1P29S-driven malignant melanoma
C. Uribe-Alvarez, S. L. Guerrero-Rodriguez, … D. Araiza-Olivera·bioRxiv·Aug 28, 2019
- Hyperactive Rac converts sublethal nibbling to lethal phagocytosis in vivo
Abhinava K. Mishra, Lauren Penfield, … Denise J. Montell·bioRxiv·Nov 28, 2025
- Unique vulnerability of RAC1-mutant melanoma to combined inhibition of CDK9 and immune checkpoints
Alexa C. Cannon, Konstantin Budagyan, … Jonathan Chernoff·bioRxiv·Jun 27, 2023
- GTP biosynthesis is a therapeutic vulnerability in Rac1-mutant melanoma
Samson Eugin Simon, Tiannan Wang, … David W. Wolff·bioRxiv·Sep 24, 2026
- New insights into the classification of the RAC1 P29S hotspot mutation in melanoma as an oncogene
Amin Mirzaiebadizi, Mohammad Reza Ahmadian·Cancer Gene TherapyPeer-reviewed·Oct 1, 2025